BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study.

Stoffel, Tanja; Bacher, Ulrike; Banz, Yara; Daskalakis, Michael; Novak, Urban; Pabst, Thomas.

Afiliação

Stoffel T; Department of Medical Oncology, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Bacher U; Department of Hematology, Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Banz Y; Institute of Pathology, University of Bern, 3010 Bern, Switzerland.
Daskalakis M; Department of Hematology, Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Novak U; Department of Medical Oncology, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
Pabst T; Department of Medical Oncology, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

J Clin Med ; 11(13)2022 Jun 28.

Article em En | MEDLINE | ID: mdl-35807041